Your search found 51 records, sorted by year and then date of acquisition.

1. Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in Multi-Site Trial. doc type
  Zhu, Yuhui ; Evans, Elizabeth A. ; Mooney, Larissa J. ; Saxon, Andrew J. ; Kelleghan, Annamarie ; Yoo, Caroline ; Hser, Yih-Ing
 Journal of Neuroimmune Pharmacology 2018 (in press). [doi: 10.1007/s11481-018-9801-x].
 
2. CTN Webinar: Where is MAT Available in the U.S. and Is It Available Where Needed? A Geographic Review. Opiate Overdose Deaths and Waivered Buprenorphine Providers: 2015. doc type
  Iguchi, Martin Y.
 Webinar presented July 30, 2018.
 
3. Pharmacogenetic Analysis of Opioid Dependence Treatment Dose and Dropout Rate. doc type
  Crist, Richard C. ; Li, James ; Doyle, Glenn A. ; Gilbert, Alex ; Dechairo, Bryan M. ; Berrettini, Wade H.
 American Journal of Drug and Alcohol Abuse 2018;44(4):431-440. [doi: 10.1080/00952990.2017.1420795].
 
4. A Polymorphism in the OPRM1 3'-Untranslated Region is Associated with Methadone Efficacy in Treatment Opioid Dependence. doc type
  Crist, Richard C. ; Doyle, Glenn A. ; Nelson, Elliot C. ; Degenhardt, Louisa ; Martin, Nicholas G. ; Montgomery, Grant W. ; Saxon, Andrew J. ; Ling, Walter ; Berrettini, Wade H.
 Pharmacogenomics Journal 2018;18(1):173-179. [doi: 10.1038/tpj.2016.89].
 
5. High Mortality Among Patients with Opioid Use Disorder in a Large Healthcare System. doc type
  Hser, Yih-Ing ; Mooney, Larissa J. ; Saxon, Andrew J. ; Miotto, Karen ; Bell, Douglas S. ; Zhu, Yuhui ; Liang, Di ; Huang, David
 Journal of Addiction Medicine 2017;11(4):315-319. [doi: 10.1097/ADM.0000000000000312].
 
6. Distinctive Trajectories of Opioid Use Over an Extended Follow-Up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone. doc type
  Hser, Yih-Ing ; Huang, David ; Saxon, Andrew J. ; Woody, George ; Moskowitz, Andrew L. ; Matthews, Abigail G. ; Ling, Walter
 Journal of Addiction Medicine 2017;11(1):63-69. [doi: 10.1097/ADM.0000000000000274].
 
7. Quitting Smoking During Substance Use Disorders Treatment: Patient and Treatment-Related Variables. doc type
  Campbell, Barbara K. ; Le, Thao ; Tajima, Barbara M. ; Guydish, Joseph R.
 Journal of Substance Abuse Treatment 2017;73:40-46. [doi: 10.1016/j.jsat.2016.11.002].
 
8. Long-Term Outcomes After Randomization to Buprenorphine/Naloxone Versus Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Evans, Elizabeth ; Huang, David ; Weiss, Roger D. ; Saxon, Andrew J. ; Carroll, Kathleen M. ; Woody, George E. ; Liu, David S. ; Wakim, Paul G. ; Matthews, Abigail G. ; Hatch-Maillette, Mary A. ; Jelstrom, Eve ; Wiest, Katharina L. ; McLaughlin, Paul ; Ling, Walter
 Addiction 2016;111(4):695-705. [doi: 10.1111/add.13238].
 
9. Examining Longitudinal Stimulant Use and Treatment Attendance as Parallel Outcomes in Two Contingency Management Randomized Clinical Trials. doc type
  McPherson, Sterling ; Brooks, Olivia ; Barbosa-Leiker, Celestina ; Lederhos, Crystal ; Lamp, Amanda ; Murphy, Sean ; Layton, Matthew E. ; Roll, John M.
 Journal of Substance Abuse Treatment 2016;61:18-25. [doi: 10.1016/j.jsat.2015.08.008].
 
10. The Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth with Opioid Dependence. doc type
  Poole, Sabrina A. ; Pecoraro, Anna ; Subramaniam, Geetha A. ; Woody, George E. ; Vetter, Victoria
 Journal of Addiction Medicine 2016;10(1):26-33. [doi: 10.1097/ADM.0000000000000176].
 
11. Opioid Addicted Buprenorphine Injectors: Drug Use During and After 12-Weeks of Buprenorphine-Naloxone or Methadone in the Republic of Georgia. doc type
  Piralishvili, Gvantsa ; Otiashvili, David ; Sikharulidze, Zura ; Kamkamidze, George ; Poole, Sabrina A. ; Woody, George E.
 Journal of Substance Abuse Treatment 2015;50:32-37. [doi: 10.1016/j.jsat.2014.10.003].
 
12. Alcohol Screening Among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program. doc type
  Klimas, Jan ; Muench, John ; Wiest, Katharina L. ; Croff, Raina ; Rieckmann, Traci R. ; McCarty, Dennis
 Journal of Psychoactive Drugs 2015;47(1):65-70. [doi: 10.1080/02791072.2014.991859].
 
13. Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study. doc type
  Schulte, Marya T. ; Hser, Yih-Ing ; Saxon, Andrew J. ; Evans, Elizabeth ; Li, Libo ; Huang, David ; Hillhouse, Maureen P. ; Thomas, Christie ; Ling, Walter
 Journal of Community Health 2015;40(5):940-947. [doi: 10.1007/s10900-015-0016-2].
 
14. Patient Perspectives on Buprenorphine/Naloxone: A Qualitative Study of Retention During the Starting Treatment with Agonist Replacement Therapies (START) Study. doc type
  Teruya, Cheryl ; Schwartz, Robert P. ; Mitchell, Shannon G. ; Hasson, Albert L. ; Thomas, Christie ; Buoncristiani, Samantha H. ; Hser, Yih-Ing ; Wiest, Katharina ; Cohen, Allan J. ; Glick, Naomi ; Jacobs, Petra ; McLaughlin, Paul ; Ling, Walter
 Journal of Psychoactive Drugs 2014;46(5):412-426. [doi: 10.1080/02791072.2014.921743].
 
15. HIV Risk Reduction with Buprenorphine-Naloxone or Methadone: Findings from A Randomized Trial. doc type
  Woody, George E. ; Bruce, R. Douglas ; Korthuis, P. Todd ; Chhatre, Sumedha ; Hillhouse, Maureen P. ; Jacobs, Petra ; Sorensen, James L. ; Saxon, Andrew J. ; Metzger, David S. ; Ling, Walter
 Journal of Acquired Immune Deficiency Syndromes 2014;66(3):288-293. [doi: 10.1097/QAI.0000000000000165].
 
16. Treatment Retention Among Patients Randomized to Buprenorphine/Naloxone Compared to Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Saxon, Andrew J. ; Huang, David ; Hasson, Albert ; Thomas, Christie ; Hillhouse, Maureen ; Jacobs, Petra ; Teruya, Cheryl ; McLaughlin, Paul ; Wiest, Katharina ; Cohen, Allan J. ; Ling, Walter
 Addiction 2014;109(1):79-87. [doi: 10.1111/add.12333].
 
17. From START to Finish: National and International Perspectives on Disseminating Research to Practice for the Treatment of Opioid Dependence. doc type
  Saxon, Andrew J. ; Woody, George E. ; Jacobs, Petra ; Crist, Richard C. ; Nurhidayat, Adhi Wibowo ; Hickman, Mathew ; Strang, John
 Blending Initiative Workshop sponsored by the National Institute on Drug Abuse (NIDA), the National Drug Abuse Treatment Clinical Trials Network (CTN), and the NIDA/SAMHSA Blending Initiative in collaboration with the American Association for the Treatment of Opioid Dependence (AATOD), Philadelphia, PA, November 10, 2013.
 
18. Characterizing Smoking, Cessation Services, and Quit Interest Across Outpatient Substance Abuse Treatment Modalities. doc type
  McClure, Erin A. ; Acquavita, Shauna P. ; Dunn, Kelly E. ; Stoller, Kenneth B. ; Stitzer, Maxine L.
 Journal of Substance Abuse Treatment 2013;46(2):194-201. [doi: 10.1016/j.jsat.2013.07.009].
 
19. Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings from Starting Treatment with Agonist Replacement Therapies (START). doc type
  Potter, Jennifer Sharpe ; Marino, Elise N. ; Hillhouse, Maureen P. ; Nielsen, Suzanne ; Wiest, Katharina ; Canamar, Catherine P. ; Martin, Judith A. ; Ang, Alfonso ; Baker, Rachel ; Saxon, Andrew J. ; Ling, Walter
 Journal of Studies on Alcohol and Drugs 2013;74(4):605-613..
 
20. 2013 Texas Addiction Research to Practice Conference. doc type doc type
  Stotts, Angela L. ; Walters, Scott ; Wakhlu, Sidarth
 Dissemination Conference sponsored by the Texas Node, Dallas, TX, April 26, 2013.
 
21. An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans. doc type
  Crist, Richard C. ; Clarke, Toni-Kim ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade
 Neuropsychopharmacology 2013;38:2003-2010. [doi: 10.1038/npp.2013.99].
 
22. Buprenorphine/Naloxone and Methadone Effects on Laboratory Indices of Liver Health: A Randomized Trial. doc type doc type
  Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ang, Alfonso ; Doraimani, Geetha ; Tasissa, Gudaye ; Lokhnygina, Yuliya ; Leimberger, Jeffrey D. ; Bruce, R. Douglas ; McCarthy, John ; Wiest, Katharina ; McLaughlin, Paul ; Bilangi, Richard ; Cohen, Allan J. ; Woody, George E. ; Jacobs, Petra
 Drug and Alcohol Dependence 2013;128(1-2):71-76. [doi: 10.1016/j.drugalcdep.2012.08.002].
 
23. HIV Rapid Testing in Drug Treatment: Comparison Across Treatment Modalities. doc type
  Schwartz, Robert P. ; Stitzer, Maxine L. ; Feaster, Daniel J. ; Korthuis, P. Todd ; Alvanzo, Anika A. H. ; Winhusen, Theresa M. ; Donnard, Lillian ; Snead, Ned ; Metsch, Lisa R.
 Journal of Substance Abuse Treatment 2013;44(4):369-374. [doi: 10.1016/j.jsat.2012.08.219].
 
24. Financial Factors and the Implementation of Medications for Treating Opioid Use Disorders. doc type
  Knudsen, Hannah K. ; Roman, Paul M.
 Journal of Addictive Medicine 2012;6(4):280-286. [doi: 10.1097/ADM.0b013e318262a97a].
 
25. Protocol: NIDA-CTN-0027: Starting Treatment with Agonist Replacement Therapies (START). doc type
  Ling, Walter ; Saxon, Andrew J.
 Presented at the American Public Health Association (APHA) annual meeting, Washington, DC, Oct. 28 - Nov. 2, 2011.
 
26. Smoking Cessation Treatment among Patients in Community-Based Substance Abuse Rehabilitation Programs: Exploring Predictors of Outcome as Clues Toward Treatment Improvement. doc type
  Reid, Malcolm S. ; Jiang, Huiping ; Fallon, Bryan ; Sonne, Susan C. ; Rinaldi, Paul ; Turrigiano, Eva ; Arfken, Cynthia L. ; Robinson, James A. ; Rotrosen, John ; Nunes, Edward V.
 American Journal of Drug and Alcohol Abuse 2011;37(5):472-478. [doi: 10.3109/00952990.2011.596981].
 
27. NIATX and the CTN: It's All About Improving Care. doc type
  Levy, Michael S.
 Presented at the NIATx Summit and State Associations of Addiction Services (SAAS) National Conference, Boston, MA, July 19-22, 2011.
 
28. Hartford Dispensary: Integrating Medical & Dental Services into an Addiction Treatment Setting. doc type
  McLaughlin, Paul
 Presented at the CTN Steering Committee Meeting, Bethesda, MD, September 21, 2010.
 
29. Men in Methadone Maintenance versus Psychosocial Outpatient Treatment: Differences in Sexual Risk Behaviors and Intervention Effectiveness from a Multisite HIV Prevention Intervention Trial. doc type
  Calsyn, Donald A. ; Campbell, Aimee N. C. ; Crits-Christoph, Paul ; Doyle, Suzanne R. ; Tross, Susan ; Hatch-Maillette, Mary A. ; Mandler, Raul N.
 Journal of Addictive Diseases 2010;29(3):370-382. [doi: 10.1080/10550887.2010.489451].
 
30. Psychosocial and Substance Use Severity in Unemployed Patients Enrolled in Methadone Maintenance and Psychosocial Abstinence-Based Programs. doc type
  Pickens, Roy W. ; Keyser-Marcus, Lori ; Sepulveda, Allison ; Snead, Ned ; Stitzer, Maxine L. ; Svikis, Dace S.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
31. START Study Retention: Perspectives of Suboxone Dropouts. doc type
  Teruya, Cheryl ; Thomas, Christie ; Rosensteel, Anya ; Hasson, Albert L. ; Hillhouse, Maureen P. ; Hser, Yih-Ing ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
32. Implementing Research in Community Treatment Programs: Findings from a CTN Trial. doc type
  Cohen, Allan J. ; George, Dan ; Langlois, Camille ; Moreno, Ann ; Yomjinda, Dara ; Boubion, Cynthia ; Martin, Judith ; Donovick, Roger ; Thomas, Christie ; Hasson, Albert L. ; Vimieiro, Cintia ; Hillhouse, Maureen P. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
33. Buprenorphine Treatment of Prescription Opiate Addiction. doc type
  McCarthy, John
 Presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
34. Motivational Incentives Research in the National Drug Abuse Treatment Clinical Trials Network. doc type
  Stitzer, Maxine L. ; Petry, Nancy M. ; Peirce, Jessica M.
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S61-S69. [doi: 10.1016/j/jsat.2009.12.010].
 
35. Using a Latent Variable Approach to Inform Gender and Racial/Ethnic Differences in Cocaine Dependence: A National Drug Abuse Treatment Clinical Trials Network Study. doc type
  Wu, Li-Tzy ; Pan, Jeng-Jong ; Blazer, Dan G. ; Tai, Betty ; Stitzer, Maxine L. ; Woody, George E.
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S70-S79. [doi: 10.1016/j.jsat.2009.12.011].
 
36. The Construct and Measurement Equivalence of Cocaine and Opioid Dependences: A National Drug Abuse Treatment Clinical Trials Network (CTN) Study. doc type
  Wu, Li-Tzy ; Pan, Jeng-Jong ; Blazer, Dan G. ; Tai, Betty ; Brooner, Robert K. ; Stitzer, Maxine L. ; Patkar, Ashwin A. ; Blaine, Jack D.
 Drug and Alcohol Dependence 2009;103(3):114-123. [doi: 10.1016/j.drugalcdep.2009.01.018].
 
37. Understanding Attitudes Toward Use of Medication in Substance Abuse Treatment: A Multilevel Approach. doc type
  Fitzgerald, John P. ; McCarty, Dennis
 Psychological Services 2009;6(1):74-84. [doi: 10.1037/a0013420].
 
38. Methadone Patients in the Therapeutic Community: A Test of Equivalency. doc type
  Sorensen, James L. ; Andrews, Siara ; Delucchi, Kevin L. ; Greenberg, Brian ; Guydish, Joseph R. ; Masson, Carmen L. ; Shopshire, Michael
 Drug and Alcohol Dependence 2009;100(1-2):100-106. [doi: 10.1016/j.drugalcdep.2008.09.009].
 
39. Methadone vs. Non-Methadone Patients in a Therapeutic Community: Test of Equivalency. doc type
  Sorensen, James L. ; Andrews, Siara ; Delucchi, Kevin L. ; Greenberg, Brian ; Guydish, Joseph R. ; Masson, Carmen L.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Juan, Puerto Rico, June 14-19, 2008.
 
40. Infrequent Illicit Methadone Use among Stimulant-Using Patients in Methadone Maintenance Treatment Programs: A National Drug Abuse Treatment Clinical Trials Network Study. doc type
  Wu, Li-Tzy ; Blazer, Dan G. ; Stitzer, Maxine L. ; Patkar, Ashwin A. ; Blaine, Jack D.
 American Journal on Addictions 2008;17(4):304-311. [doi: 10.1080/10550490802138913].
 
41. Implementation of Contingency Management within Two New York City Methadone Programs. doc type
  Kellogg, Scott ; Brandau, Susan L.
 Presented at the NIDA Blending Conference, "Blending Addiction Science & Treatment: The Impact of Evidence-Based Practices on Individuals, Families, and Communities," Cincinnati, OH, June 2-3, 2008.
 
42. Implementation of a Smoking Cessation Treatment Study at Substance Abuse Rehabilitation Programs: Smoking Behavior and Treatment Feasibility Across Varied Community-Based Outpatient Programs. doc type
  Reid, Malcolm S. ; Fallon, Bryan ; Sonne, Susan C. ; Nunes, Edward V. ; Lima, Jennifer ; Jiang, Huiping ; Tyson, Clare ; Hiott, Robert ; Arfken, Cynthia L. ; Bohs, Rhonda ; Orr, Deborah ; Muir, Joan A. ; Pihlgren, Eric ; Loree, Amy ; Fuller, Bret E. ; Giordano, Louis ; Robinson, James A. ; Rotrosen, John
 Journal of Addiction Medicine 2007;1(3):154-160.
 
43. Smoking Cessation Treatment in Community-Based Substance Abuse Rehabilitation Programs. doc type doc type
  Reid, Malcolm S. ; Fallon, Bryan ; Sonne, Susan C. ; Flammino, Frank ; Nunes, Edward V. ; Jiang, Huiping ; Kourniotis, Eva ; Lima, Jennifer ; Brady, Ronald ; Burgess, Cynthia ; Arfken, Cynthia L. ; Pihlgren, Eric ; Giordano, Louis ; Starosta, Aron ; Robinson, James A. ; Rotrosen, John
 Journal of Substance Abuse Treatment 2008;35(1):68-77. [doi: 10.1016/j.jsat.2007.08.010].
 
44. Abstinence-Based Incentives in Methadone Maintenance: Interaction with Intake Stimulant Test Results. doc type
  Stitzer, Maxine L. ; Peirce, Jessica M. ; Petry, Nancy M. ; Kirby, Kimberly C. ; Roll, John M. ; Krasnansky, Joseph ; Cohen, Allan J. ; Blaine, Jack D. ; Vandrey, Ryan ; Kolodner, Ken B. ; Li, Rui
 Experimental and Clinical Psychopharmacology 2007;15(4):344-350. [doi: 10.1037/1064-1297.15.4.344].
 
45. Cost-Effectiveness of Prize-Based Contingency Management in Methadone Maintenance Treatment Programs. doc type
  Sindelar, Jody L. ; Olmstead, Todd A. ; Peirce, Jessica M.
 Addiction 2007;102(9):1463-1471. [doi: 10.1111/j.1360-0443.2007.01913.x].
 
46. Abstinence Incentives for Methadone-Maintained Stimulant Users : Outcomes for Those Testing Stimulant-Positive versus Negative at Study Intake. doc type
  Stitzer, Maxine L.
 Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Quebec City, Canada, June 16-21, 2007.
 
47. Clinical Trials Network: Counselor-Level Data on Evidence-Based Treatment Practices. doc type
  Roman, Paul M. ; Johnson, J. Aaron ; Ducharme, Lori J. ; Knudsen, Hannah K.
 Atlanta, GA: Institute for Behavioral Research, University of Georgia, NTCS Report No. 11, February 2006, 44p..
 
48. Effects of Lower-Cost Incentives on Stimulant Abstinence in Methadone Maintenance Treatment: A National Drug Abuse Treatment Clinical Trials Network Study. doc type doc type
  Peirce, Jessica M. ; Petry, Nancy M. ; Stitzer, Maxine L. ; Blaine, Jack D. ; Kellogg, Scott ; Satterfield, Frank ; Schwartz, Marion ; Krasnansky, Joseph ; Pencer, Eileen ; Silva-Vazquez, Lolita ; Kirby, Kimberly C. ; Royer-Malvestuto, Charlotte ; Roll, John M. ; Cohen, Allan J. ; Copersino, Marc L. ; Kolodner, Ken B.
 Archives of General Psychiatry 2006;63(2):201-208.
 
49. Something of Value: The Introduction of Contingency Management Interventions into the New York City Health and Hospital Addiction Treatment Service. doc type
  Kellogg, Scott ; Burns, Marylee ; Coleman, Peter ; Stitzer, Maxine L. ; Wale, Joyce B. ; Kreek, Mary Jeanne
 Journal of Substance Abuse Treatment 2005;28:57-65. [doi: 10.1016/j.jsat.2004.10.007].
 
50. CTN MIEDAR Studies. Baseline Comparison : Methadone vs Psychosocial Participants. doc type
  Stitzer, Maxine L.
 Presented at the 14th Annual Meeting of the American Academy of Addiction Psychiatry (AAAP), New Orleans, LA, December 4-7, 2003.
 
51. Motivational Incentives : A Study of New Ways to Help People Remain Abstinent. Should I Join the Motivational Incentives Study? (Methadone Clinics) doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 


Powered by DB/Text WebPublisher, from Inmagic WebPublisher PRO